An effective molecular design successfully captures the balance, proportion and rhythm of a specific biomolecule while respecting the unity of the biomolecule with its cellular, tissue, whole organism and ecological surroundings. I propose to lead the design of a drug that crosslinks two proteins of the gliding motility machinery of P. falciparum: the causative agent of malaria. This molecule will be a novel malaria treatment operating directly at the complicated host-pathogen interface and influencing the enormous global health burden of this disease. First, the inter-locking parts of the gliding motility machinery will be visualized by a combination of novel molecular modeling approaches and X-ray crystallography. Of note, three- dimensional visualization of the first interlocking part failed via either of these approaches separately, but we succeeded by cleverly deploying them in an integrated fashion. Additional interlocking pieces of the gliding motility machine are already being unveiled by this unique approach, so we are confident that we can visualize the intricacies of a large bloc of the molecular machine in its in situ configuraion. Second, exploitable pockets in the whole machine will be targeted for drug design via a combination of in silico screening of chemical databases and novel cheminformatics techniques. We describe how this integrated approach revealed a hitherto unrecognized "druggable" site, allowing the biology to guide the design.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
NIH Director’s New Innovator Awards (DP2)
Project #
4DP2OD004631-02
Application #
8786467
Study Section
Special Emphasis Panel (ZGM1-NDIA-G (01))
Program Officer
Basavappa, Ravi
Project Start
2008-09-30
Project End
2015-12-31
Budget Start
2014-01-01
Budget End
2015-12-31
Support Year
2
Fiscal Year
2014
Total Cost
$508,500
Indirect Cost
$208,500
Name
New York University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Wang, Wenjuan; Li, Tianqi; Felsovalyi, Klara et al. (2014) Quantitative analysis of T cell receptor complex interaction sites using genetically encoded photo-cross-linkers. ACS Chem Biol 9:2165-72
Cardozo, Timothy; Wang, Shixia; Jiang, Xunqing et al. (2014) Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes. Vaccine 32:4916-24
Martin, Leenus; Grigoryan, Arsen; Wang, Ding et al. (2014) Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations. Cancer Res 74:3104-13
Malecek, Karolina; Grigoryan, Arsen; Zhong, Shi et al. (2014) Specific increase in potency via structure-based design of a TCR. J Immunol 193:2587-99
Pavlides, Savvas C; Huang, Kuang-Tzu; Reid, Dylan A et al. (2013) Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Endocrinology 154:4030-45
Weiser, Keren; Barton, Meredith; Gershoony, Dafna et al. (2013) HIV's Nef interacts with *-catenin of the Wnt signaling pathway in HEK293 cells. PLoS One 8:e77865
Shmelkov, Evgeny; Nadas, Arthur; Swetnam, James et al. (2011) Indirect detection of an epitope-specific response to HIV-1 gp120 immunization in human subjects. PLoS One 6:e27279
Allen, Gregory S; Wu, Chen-Chou; Cardozo, Tim et al. (2011) The architecture of CopA from Archeaoglobus fulgidus studied by cryo-electron microscopy and computational docking. Structure 19:1219-32
Shmelkov, Evgeny; Tang, Zuojian; Aifantis, Iannis et al. (2011) Assessing quality and completeness of human transcriptional regulatory pathways on a genome-wide scale. Biol Direct 6:15
Agarwal, Alpna; Hioe, Catarina E; Swetnam, James et al. (2011) Quantitative assessment of masking of neutralization epitopes in HIV-1. Vaccine 29:6736-41